Course overview
This intensive, one-day course provides a clear, structured, and highly accessible introduction to how the pharmaceutical and biotechnology industries operate - from early molecule discovery through development, regulatory approval, and commercialisation.
Designed specifically for non-scientists and those new to the sector, the programme demystifies complex processes, terminology, and decision-making across the drug development lifecycle. It explains how different functions contribute at each stage and how they work together in practice, helping participants understand not just what happens, but why it happens.
The course also reflects how the industry is evolving. Alongside core fundamentals, participants will gain an overview of current innovations, including the growing role of artificial intelligence (AI) in discovery, development, and clinical operations, and what this means for the future of pharma and biotech.
The focus throughout is on clarity, real-world context, and practical understanding - not deep science.
CPD Hours: 6
Course Content
- Day 1
- How medicines are developed
- Discovery and early development
- Clinical development
- Safety and regulation
- Commercial considerations
Speakers
Laura Brown
Dr Laura Brown is a pharmaceutical management consultant and Senior Lecturer of the MSc in Clinical Research at the School of Pharmacy, University of Cardiff. Laura has more than 25 years’ experience in the pharmaceutical industry and has held senior positions with companies such as GSK, Hoechst Marion Roussel, Farmitalia and Phoenix International. She regularly writes on pharmaceutical drug development and regulatory issues including ‘The Planning of International Drug Development’ in the Clinical Research Manual and ‘The Impact of Brexit’ in the RQA journal.
